Putzu, C.; Serra, R.; Campus, R.; Fadda, G.M.; Sini, C.; Marongiu, A.; Ginesu, G.C.; Fois, A.G.; Palmieri, G.; Zinellu, A.;
et al. Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy. Curr. Oncol. 2024, 31, 4955-4967.
https://doi.org/10.3390/curroncol31090367
AMA Style
Putzu C, Serra R, Campus R, Fadda GM, Sini C, Marongiu A, Ginesu GC, Fois AG, Palmieri G, Zinellu A,
et al. Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy. Current Oncology. 2024; 31(9):4955-4967.
https://doi.org/10.3390/curroncol31090367
Chicago/Turabian Style
Putzu, Carlo, Riccardo Serra, Rachele Campus, Giovanni Maria Fadda, Claudio Sini, Andrea Marongiu, Giorgio Carlo Ginesu, Alessandro Giuseppe Fois, Giuseppe Palmieri, Angelo Zinellu,
and et al. 2024. "Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy" Current Oncology 31, no. 9: 4955-4967.
https://doi.org/10.3390/curroncol31090367
APA Style
Putzu, C., Serra, R., Campus, R., Fadda, G. M., Sini, C., Marongiu, A., Ginesu, G. C., Fois, A. G., Palmieri, G., Zinellu, A., Cossu, A., & Paliogiannis, P.
(2024). Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy. Current Oncology, 31(9), 4955-4967.
https://doi.org/10.3390/curroncol31090367
